ITRM News and Press, Iterum Therapeutics plc

Aptevo Therapeutics Inc. (APVO) is expected to report $-8.09 for Q4 2025 Longeveron Inc. (LGVN) is expected to report $-0.41 for Q4 2025 Genesco Inc. (GCO) is expected to report $3.73 for Q4 2026 Algonquin Power & Utilities Corp. (AQN) is expected to report $0.04 for Q4 2025 N...

A look at the top 10 most actives in the United States Mobix Labs Inc. (MOBX) rose 532.8% to $1.12 on volume of 1,386,331,312 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 15.1% to $2.06 on volume of 1,262,822,550 shares Trio Petroleum Corp. (TPET) rose 74.1% to $1.95 on vo...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 14.2% to $2.045 on volume of 1,167,354,892 shares Mobix Labs Inc. (MOBX) rose 447.6% to $0.9693 on volume of 1,145,176,307 shares Trio Petroleum Corp. (TPET) rose 66.8% to $1.8681 ...

Sunstone Hotel Investors Inc. (SHO) is expected to report $0.18 for Q4 2025 GT Biopharma Inc. (GTBP) is expected to report $-0.22 for Q4 2025 Global Partners LP representing Limited Partner Interests (GLP) is expected to report $0.6 for Q4 2025 4D Molecular Therapeutics Inc. (FDMT) is...

--Expanded Market Access and Patent Protection for ORLYNVAH™ --FDA correspondence regarding the use of ORLYNVAH™   as step-down therapy DUBLIN and CHICAGO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “I...

Air Canada Inc. (ACDVF) is expected to report $0.2 for Q4 2025 Edesa Biotech Inc. (EDSA) is expected to report $-0.28 for Q1 2026 Advance Auto Parts Inc. (AAP) is expected to report $0.41 for Q4 2025 Neuphoria Therapeutics Inc. (NEUP) is expected to report $-0.56 for Q2 2026 Kirin...

Biogen Inc. (BIIB) is expected to report $1.6 for Q4 2025 Frontier Group Holdings Inc. (ULCC) is expected to report $0.02 for Q4 2025 Johnson Outdoors Inc. (JOUT) is expected to report $-0.45 for Q1 2026 Piper Sandler Companies (PIPR) is expected to report $4.72 for Q4 2025 Ispire...

2026-02-05 17:39:25 ET Iterum Therapeutics plc (ITRM) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 7.07%. The average open to low on the day of earnings was -5.18%. The average open t...

2026-02-05 17:34:26 ET Iterum Therapeutics plc (ITRM) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in ITRM stock price following earnings has averaged ±5.09% , with a median of 4.26%. ...

2025-11-14 11:12:11 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript Iterum Therapeutics Non-GAAP EPS of -$0.16, revenue of $0.39M Seeking Alpha’s Quant Rating on Iterum Therapeutics Historical earnings dat...